1 in 3 people in the U.S. will receive a cancer diagnosis in their lifetime. Unfortunately, many people face unnecessary barriers to timely and equitable screening, treatment and support. To help close these gaps, the American Cancer Society (ACS) and Pfizer recently launched a new initiative, "Change the Odds: Uniting to Improve Cancer Outcomes," aimed at addressing cancer disparities and improving health outcomes in medically underrepresented communities across the United States.
